Evidence map›Paper›PMID 21098662›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Caveolin-1 knockout mice exhibit impaired induction of mGluR-dependent long-term depression at CA3-CA1 synapses.

Yukihiro Takayasu, Koichi Takeuchi, Ranju Kumari, Michael V L Bennett, R Suzanne Zukin, Anna Francesconi

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Metabotropic glutamate receptor trafficking.Molecular and cellular neurosciences · 2018
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Caveolin-1 in the anterior cingulate cortex modulates chronic neuropathic pain via regulation of NMDA receptor 2B subunit.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yukihiro TakayasuThe Dominick P Purpura Department of Neuroscience, The Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Koichi Takeuchi
Ranju Kumari
Michael V L Bennett
R Suzanne Zukin
Anna Francesconi
Albert Einstein College of Medicine · US

Funding

PURIFICATION OF NEUROBLASTOMA OPIATE RECEPTORSR01NS020752 · NINDS · YESHIVA UNIVERSITY · PI ZUKIN, R. SUZANNE · 1985 to 2009
$3.6M
Regulation of Metabotropic glutamate Receptor Signaling by Caveolar RaftsR01MH082870 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI FRANCESCONI, ANNA · 2009 to 2013
$2.0M
Cx43 Hemichannels: Gating, Modification and FunctionR01NS055363 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI BENNETT, MICHAEL V L · 2007 to 2011
$1.6M
NIMH NIH HHS MH082870NIMH NIH HHS R01 MH082870NINDS NIH HHS NS20752NINDS NIH HHS NS55363NINDS NIH HHS R01 NS020752NINDS NIH HHS R01 NS055363
6 · The paper itself

Abstract

Group I metabotropic glutamate receptors (mGluR1/5) are important to synaptic circuitry formation during development and to forms of activity-dependent synaptic plasticity. Dysregulation of mGluR1/5 signaling is implicated in some disorders of neurodevelopment, including fragile X syndrome, the most common inherited form of intellectual disabilities and leading cause of autism. Site(s) in the intracellular loops of mGluR1/5 directly bind caveolin-1, an adaptor protein that associates with membrane rafts. Caveolin-1 is the main coat component of caveolae and organizes macromolecular signaling complexes with effector proteins and membrane receptors. We report that long-term depression (LTD) elicited by a single application of the group I mGluR selective agonist (RS)-3,5-dihydroxyphenylglycine (DHPG) was markedly attenuated at Schaffer collateral-CA1 synapses of mice lacking caveolin-1 (Cav1(-/-)), as assessed by field recording. In contrast, multiple applications of DHPG produced LTD comparable to that in WT mice. Passive membrane properties, basal glutamatergic transmission and NMDA receptor (NMDAR)-dependent LTD were unaltered. The remaining LTD was reduced by anisomycin, an inhibitor of protein synthesis, by U0126, an inhibitor of MEK1/2 kinases, and by rapamycin, an inhibitor of mammalian target of rapamycin (mTOR), suggesting mediation by the same mechanisms as in WT. mGluR1/5-dependent activation (phosphorylation) of MEK and extracellular signal-regulated kinase (ERK1/2) was altered in Cav1(-/-) mice; basal phosphorylation was increased, but a single application of DHPG had no further effect, and after DHPG, phosphorylation was similar in WT and Cav1(-/-) mice. Taken together, our findings suggest that caveolin-1 is required for normal coupling of mGluR1/5 to downstream signaling cascades and induction of mGluR-LTD.

Indexed as

AnimalsAntibiotics, AntineoplasticButadienesCaveolin 1Enzyme InhibitorsExcitatory Amino Acid AgonistsExtracellular Signal-Regulated MAP KinasesGlycineHippocampusLong-Term Synaptic DepressionMiceMice, Inbred C57BLMice, KnockoutNitrilesPatch-Clamp TechniquesReceptors, Metabotropic Glutamate3,5-dihydroxyphenylglycineAntibiotics, AntineoplasticButadienesCaveolin 1Enzyme InhibitorsExcitatory Amino Acid AgonistsExtracellular Signal-Regulated MAP KinasesGlycineNitrilesReceptors, Metabotropic GlutamateResorcinolsSirolimusTOR Serine-Threonine KinasesU 0126

Identifiers

PMID21098662
PMCPMC3003045
OpenAlexW2108519566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.